Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Designed as a triple agonist compound, Retatrutide has been studied for its activity across glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptor pathways
doi: 10.14309/ajg.0000000000001781 31
Maintenance therapy generally requires monthly injections, though some individuals benefit from biweekly administration depending on their bodys utilization rate and any ongoing absorption challenges
A separate analysis in Nature Medicine found that retatrutide produced significant reductions in liver fat content in participants with metabolic dysfunction-associated steatotic liver disease (MASLD), suggesting benefits beyond simple weight reduction
Esophagus 27 , 645653 (2014)
US$ 22.73
US$ 21.20
US$ 26.03
US$ 24.84
